Semax 10mg

Description

Semax 10mg, documented for a careful laboratory review

Purity Collective supplies Semax 10mg in a lyophilized vial for qualified laboratory research. This page brings the catalog identity, stated quantity, SKU and available analytical records together so procurement teams can review the listing from the source documents.

Analytical records are most useful when their scope is clear. Confirm the compound and lot identifiers, reported methods, dates, specifications and results in the full documents before making an internal acceptance decision. Results from one submitted sample should not be treated as a guarantee for every unit.

Product details

Available analytical documents

Open the Semax 10mg UPLC/MS report and the Semax endotoxin report to review the complete records. Purity Collective’s guide to reading a peptide COA explains how to compare identity, lot, method, date, specification and result fields. For Selank/Semax format comparison and evidence boundaries, read the Selank and Semax research records guide.

The UPLC/MS report identifies Semax and lists lot PCCL-1902514-P. For that submitted sample, it records a measured quantity of 9.8mg against a 10mg specification and a purity result of 99.18% against a greater-than-98% specification. These figures describe the reported sample only.

The separate endotoxin report identifies lot PCCL-1902514-E and records a result below 0.05 EU/mL. It does not print an endotoxin acceptance specification. Both documents display an analysis date of May 4, 2026 and a received date of May 9, 2026, meaning the stated analysis date is earlier than the stated received date. Buyers should consider that chronology during document review. The reports do not establish sterility, safety, suitability or performance.

Why Purity Collective presents the full record

Qualified procurement depends on traceable information, not an isolated headline number. Purity Collective connects the product identity and supplied format to the available documents while distinguishing catalog details from sample-specific measurements. That separation gives laboratories a clearer starting point for supplier qualification and their own acceptance process.

Before you order

• Confirm that Semax, the 10mg listed quantity and SKU PC-SEMAX-10MG match the procurement request.
• Review both reports in full, including their separate lot identifiers, methods, dates, specifications and results.
• Note the 9.8mg measured quantity, the missing printed endotoxin acceptance specification and the displayed date chronology.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

Semax 10mg FAQs

What is included in this Semax 10mg listing?

The listing identifies Semax with a stated quantity of 10mg, supplied in a lyophilized vial under SKU PC-SEMAX-10MG for qualified laboratory research.

Which analytical documents are available?

The page links directly to a two-page UPLC/MS report and a separate endotoxin report. Each document should be reviewed as a complete record, including its compound, lot, method, dates, specification fields and results.

What does the Semax UPLC/MS report show?

For submitted lot PCCL-1902514-P, the report records a measured quantity of 9.8mg and a purity result of 99.18%. These are sample-specific results, not universal guarantees.

What limitations should be noted in the reports?

The endotoxin report does not print an acceptance specification. Both reports also show May 4, 2026 as the analysis date and May 9, 2026 as the received date, so the displayed chronology requires buyer review.

Is Semax 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.